Mood Stabiliser Teratogenicity
On this page
Direct answer
Valproate sits at the top of the teratogenic league among mood stabilisers: roughly one in ten exposed pregnancies results in a major malformation — neural tube defects, cardiac, renal and limb anomalies — plus neurodevelopmental impairment in a further proportion, which is why it is contraindicated in pregnancy and in women who can become pregnant unless no alternative exists and a pregnancy-prevention conversation is documented; Indian product labels now carry this warning in line with international action. Carbamazepine roughly doubles baseline malformation risk with neural tube defects of its own; lithium's classic association is Ebstein anomaly, though in absolute terms the risk is about 1 in 1000, and continuation with level monitoring is often safer for both mother and baby than relapse. Lamotrigine is the safest antiepileptic-type option at around 3% malformation risk. Every woman of childbearing age on these drugs receives folic acid 5 mg daily before conception, and severe episodes in pregnancy are managed with olanzapine or quetiapine, with ECT for the most dangerous presentations.
What you must remember
- Valproate: major malformation risk of about 10% (dose-related, highest above 1000 mg/day) and neurodevelopmental delay; contraindicated in pregnancy unless no alternative — effective contraception mandatory, and Indian labels now warn accordingly.
- Carbamazepine: risk roughly 5%, neural tube defects and (in Asian populations) the separate HLA-B*15:02 Stevens-Johnson risk.
- Lithium: Ebstein anomaly of the tricuspid valve, absolute risk roughly 1 in 1000; if continued in pregnancy, monitor levels each trimester (target lower therapeutic), at delivery, and in the neonate.
- Lamotrigine: about 3% malformation risk — relatively safest of the antiepileptics — but pregnancy doubles its clearance, so levels and dose need review each trimester.
- Topiramate: oral clefts — not a mood option in women planning pregnancy.
- Folic acid 5 mg daily before conception and through the first trimester for every woman on an antiepileptic mood stabiliser; enzyme-inducing drugs additionally call for neonatal vitamin K.
- Acute mania in pregnancy: olanzapine or quetiapine are the usual antipsychotics; severe life-threatening illness justifies ECT, which is safe in pregnancy.
- Postpartum: relapse risk is at its lifetime peak — restart prophylaxis early, and breastfeeding is compatible with lamotrigine, valproate and most atypicals with infant monitoring.
A preconception consultation
A 26-year-old woman with bipolar I disorder, stable for two years on valproate 1000 mg daily, announces she is planning pregnancy. The correct sequence is deliberate: confirm that she is truly stable; begin folic acid 5 mg; switch the valproate — cross to lamotrigine started low and titrated slowly over six weeks, or to an antipsychotic such as quetiapine — and maintain contraception until the switch is proven tolerable, because a relapse into mania during the change endangers the pregnancy as surely as any drug. If she conceives unexpectedly on valproate, the drug is stopped or minimised at once, a detailed anomaly scan at 18-20 weeks with fetal echocardiography follows, and the couple is counselled honestly about the 10% figure rather than reassured vaguely.
Contrast lithium: a first-trimester exposure does not mandate termination; it mandates a fetal echocardiogram and a shared decision, because untreated maternal mania carries its own fetal risk from dehydration, impulsivity and medication chaos. The different tone of the two consultations — valproate avoided, lithium monitored — is the distinction examiners probe.
Where students slip
The predictable slip is ranking: asked which mood stabiliser is most teratogenic, candidates hesitate between carbamazepine and valproate — valproate is unambiguously the worst, and "10%" is the quotable number. The second is overreacting to lithium: Ebstein anomaly is the association, but the absolute risk is low, and the modern answer for a pregnant lithium user is monitored continuation, not automatic discontinuation — stopping abruptly stacks postpartum relapse on top of fetal exposure. Third, the folate dose: 5 mg daily is the preconception prescription for women on antiepileptics, an order of magnitude above routine antenatal 400 micrograms, and stems test exactly that digit.
Frequently asked questions
Which mood stabiliser carries the highest teratogenic risk?
Valproate, with about a 10% major malformation rate plus neurodevelopmental impairment — it is contraindicated in women who can become pregnant unless no alternative exists and pregnancy prevention is assured.
What is Ebstein anomaly and which drug causes it?
A downward-displaced tricuspid valve producing atrialisation of the right ventricle, classically associated with first-trimester lithium at an absolute risk of roughly 1 in 1000.
Which mood stabiliser is safest in pregnancy?
Lamotrigine, with a malformation rate around 3% — still above baseline, and its clearance doubles in pregnancy so dose review is required each trimester.
What dose of folic acid is given before conception with antiepileptics?
5 mg daily, continued through the first trimester, compared with 400 micrograms in routine antenatal use.
How is severe mania treated in pregnancy?
With an antipsychotic such as olanzapine or quetiapine at the lowest effective dose, reserving ECT for life-threatening illness — it is safe and often faster than any drug.